The principal scientific journal for the profession in New Zealand

Issue Vol 133 No 1515: 22 May 2020

The Government’s proposal to legalise cannabis in New Zealand: 10 key questions

ARTICLE
Vol 133 No 1515: 22 May 2020

Attitudes towards cannabis and cannabis law change in a New Zealand birth cohort

Cannabis use is widespread within New Zealand, with an estimated 70–80% of the population having tried cannabis by age 25.

ARTICLE
Vol 133 No 1515: 22 May 2020

The New Zealand nuclear veteran and families study, exploring the options to assess heritable health outcomes | OPEN ACCESS

Over the past century, knowledge regarding the harmful effects of exposure to radiation has increased. It is now known that exposure to radiation can damage living cells by altering DNA.

ARTICLE
Vol 133 No 1515: 22 May 2020

Exploring medicinal use of cannabis in a time of policy change in New Zealand

Despite limited scientific evidence for the medicinal benefits of cannabis (ie, double blind placebo-controlled trials), a growing number of countries have facilitated greater legal access to cannabis and/or cannabis-based preparations for medicinal use, including Australia, UK, Canada, Germany, Israel, Netherlands and over half of US states.

ARTICLE
Vol 133 No 1515: 22 May 2020

Change in smoking intentions of university students in New Zealand following simulated cigarette price increases: results of the first of two cross-sectional surveys | OPEN ACCESS

Smoking remains one of the leading causes of preventable death and illness in New Zealand and elsewhere. Each year about 5,000 people in New Zealand die because of smoking or second-hand smoke exposure.

ARTICLE
Vol 133 No 1515: 22 May 2020

Cannabis-based medicinal products in arthritis, a painful conundrum

The legal climate regarding the medicinal use of cannabinoids and the public advocacy for access to cannabis-based medicinal products has been changing over the years.

ARTICLE
Vol 133 No 1515: 22 May 2020

Increasing burden of advanced hepatocellular carcinoma in New Zealand—the need for better surveillance

Viral hepatitis accounts for the vast majority of newly diagnosed hepatocellular carcinoma (HCC) worldwide.

ARTICLE
Vol 133 No 1515: 22 May 2020

Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital

Osteoporosis is a disease characterised by low bone mass, micro-architectural disruption and skeletal fragility resulting in decreased bone strength and increased risk of fracture.

ARTICLE
Vol 133 No 1514: 8 May 2020

An estimate of limited duration cancer prevalence in New Zealand using ‘big’ data

A larger number of people are being diagnosed with cancer in New Zealand, while cancer mortality is decreasing, meaning more people living beyond a cancer diagnosis.

ARTICLE
Vol 133 No 1514: 8 May 2020

Early identification of infants at risk of cerebral palsy: developing the use of general movement assessment in routine clinical practice in a tertiary neonatal unit in New Zealand

Infants born preterm (<37/40 gestation) have an increased risk of a range of neurodevelopmental disorders including learning difficulties, language and motor impairments, and social and emotional problems.

ARTICLE
Vol 133 No 1514: 8 May 2020

Non-resident orthopaedic admissions to Dunedin Hospital 1997 to 2017 and Southland Hospital 2011 to 2017

Over the past several decades, New Zealand’s tourism industry has experienced exceptional growth, and forecasts for the sector indicate this expansion will continue. Statistics New Zealand has recorded that New Zealand attracted 3.5 million international visitors in the year ending December 2016.